Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunostimulatory sequences in immunotherapy.

Deidra A Blanks1

  • 1Department of Otolaryngology-Head and Neck Surgery, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7070, USA. dblanks@med.unc.edu

Current Opinion in Otolaryngology & Head and Neck Surgery
|July 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune modulatory oligonucleotides in the prevention and treatment of allergen-induced eustachian tube dysfunction in the animal model.

Current allergy and asthma reports·2008
Same author

Interaural time discrimination of envelopes carried on high-frequency tones as a function of level and interaural carrier mismatch.

Ear and hearing·2008
Same author

Behavioral sensitivity to interaural time differences in the rabbit.

Hearing research·2007
Same author

Immune modulatory oligonucleotides in prevention of nasal allergen-induced Eustachian tube dysfunction in rats.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2007
Same author

Immune modulatory oligonucleotides in the prevention and treatment of OVA-induced eustachian tube dysfunction in rats.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2007
Same author

Neural and behavioral sensitivity to interaural time differences using amplitude modulated tones with mismatched carrier frequencies.

Journal of the Association for Research in Otolaryngology : JARO·2007
Same journal

Photon-counting detector computed tomography for temporal bone: does higher resolution matter?

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Advances in patient-specific 3D-printed models in temporal bone surgery.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Graduated autonomy in head and neck microvascular surgery fellowship training: oncologic and reconstructive competency, safety, and educational implications.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Costs and system-wide considerations within head and neck reconstruction: moving toward a value-based care framework.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Modern methods of dorsal augmentation rhinoplasty.

Current opinion in otolaryngology & head and neck surgery·2026
Same journal

Flap selection for circumferential pharyngeal reconstruction.

Current opinion in otolaryngology & head and neck surgery·2026
See all related articles

Immunostimulatory DNA sequences, like CpG oligonucleotides (ODNs), show promise for treating allergies by shifting immune responses. Early trials indicate they are safe and effective, offering a potentially superior immunotherapy option.

Area of Science:

  • Immunology
  • Allergology
  • Pharmacology

Background:

  • Allergic diseases are primarily mediated by a Th2 immune response.
  • Current immunotherapies have limitations in efficacy and duration.
  • Immunostimulatory DNA sequences offer a novel therapeutic approach.

Purpose of the Study:

  • To review literature on DNA-based immunotherapy using immunostimulatory sequences.
  • To examine signaling mechanisms, cytokine profiles, and structural characteristics.
  • To assess the applicability and success in treating allergic diseases.

Main Methods:

  • Literature review of studies on CpG oligonucleotides (CpG ODNs) and immunotherapy.
  • Analysis of species-specific binding to toll-like receptors.

Related Experiment Videos

  • Evaluation of effects on cytokine profiles and immune pathways (Th1/Th2).

    • Main Results:

    • CpG ODNs bind to toll-like receptors in a species-specific manner.
    • CpG ODNs promote a Th1 immune response and suppress the Th2 pathway.
    • Studies show CpG ODNs can prevent and reverse allergic inflammation, airway hyper-reactivity, and remodeling.
    • Early human and animal trials demonstrate CpG ODNs are well-tolerated and effective.

    Conclusions:

    • Immunostimulatory DNA sequences are a promising immunotherapy strategy for allergic diseases.
    • CpG ODN immunotherapy is well-tolerated and effective in early-stage development.
    • This approach may offer a more rapid, efficacious, and longer-lasting therapy compared to current methods.